Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-07-22Clinical Trial Update: Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease [Phase 1]
A Phase 1 trial of TheraSphere in combination with Everolimus for neuroendocrine tumors with liver-dominant disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors [Phase 1]
Phase 1 trial update of sorafenib in combination with RAD001 (everolimus) in patients with advanced neuroendocrine tumors, including carcino…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68Ga-DOTATATE PET imaging in patients with neuroendocrine tumors to assess diagnostic performance.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors [Phase 2]
Phase II trial results for a capecitabine, oxaliplatin, and bevacizumab regimen in metastatic/unresectable neuroendocrine tumors were posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: 124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors. [Phase 2]
This entry describes a Phase 2 clinical trial evaluating 124I-MIBG tracer for assessing myocardial sympathetic denervation and imaging neuro…
-
FDA approval · 2013-05-23FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Octreotide acetate submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples [NA]
Completed clinical trial evaluating methods for determining Chromogranin A in routine blood samples in patients with neuroendocrine tumors (…
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG [Phase 1]
Phase I trial evaluating safety, distribution, and radiation dosimetry of ultratrace iobenguane I-123 (MIBG); the study in neuroendocrine tu…
-
CLINICAL_TRIALS research · 2012-09-18Clinical Trial Update: Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours
This clinical trial update examines whether heart/mediastinal ratio measurements at 1 or 2 hours can be equivalent to the traditional 4-hour…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization [Phase 2]
Phase II study evaluating sunitinib malate after hepatic artery embolization in neuroendocrine and islet cell tumors; the trial is completed…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial evaluating internal radiation therapy for liver metastases from neuroendocrine tumors was terminated.
-
CLINICAL_TRIALS research · 2012-04-03Clinical Trial Update: 89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors
A completed clinical trial investigating PET imaging with 89Zr-labeled bevacizumab to visualize neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 safety and efficacy study of PTK787/ZK222584 for metastatic neuroendocrine tumors has completed, per this clinical trial update.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 clinical trial update of Quarfloxin (CX-3543) in patients with low to intermediate grade neuroendocrine tumors completed.
-
CLINICAL_TRIALS research · 2011-03-03Clinical Trial Update: Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors [Phase 2]
Phase 2 trial investigating hyperthermia/thermal therapy with chemotherapy for inoperable or metastatic tumors. The listed conditions includ…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma [Phase 2]
A Phase 2 trial evaluating everolimus (RAD001) in combination with octreotide depot in metastatic or unresectable low-grade neuroendocrine t…
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: Gastrointestinal Motility in Patients With Neuroendocrine Tumors
Completed clinical trial evaluating gastrointestinal motility in patients with neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2010-09-23Clinical Trial Update: Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
An update on a neoadjuvant peptide receptor radiotherapy trial using Lutetium-177 before liver transplantation for neuroendocrine tumor live…
-
CLINICAL_TRIALS research · 2010-06-03Clinical Trial Update: ProGRP, CgA, NSE and TUM2-PK in in Patients With Neuroendocrine Tumors
This clinical trial update investigates biomarkers ProGRP, CgA, NSE, and TUM2-PK in patients with neuroendocrine tumors. The current status …
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features [Phase 1]
A Phase 1 safety study update evaluating Seneca Valley Virus in patients with solid tumors exhibiting neuroendocrine features.
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: High Dose Somatostatin Analogues in Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating high-dose somatostatin analogues in neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating thalidomide in combination with temozolomide (Temodar) for neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors
This entry provides an update on a clinical trial evaluating Ga-68-DOTA-NOC PET imaging for patients with neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2009-02-04Clinical Trial Update: Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors
An ongoing Rutgers-sponsored clinical trial investigates MEN1 and SDHD in familial carcinoid tumors, a type of neuroendocrine cancer. The cu…